DiNuzzo Private Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.84K Sell
17
-1
-6% -$212 ﹤0.01% 468
2026
Q2
$3.89K Buy
18
+1
+6% +$191 ﹤0.01% 470
2026
Q1
$3.12K Buy
17
+3
+21% +$553 ﹤0.01% 503
2025
Q4
$2.46K Buy
14
+12
+600% +$1.96K ﹤0.01% 573
2025
Q3
$265 Hold
2
– – ﹤0.01% 1228
2025
Q2
$252 Sell
2
-30
-94% -$3.74K ﹤0.01% 1214
2025
Q1
$4.38K Sell
32
-5
-14% -$715 ﹤0.01% 383
2024
Q4
$5.66K Sell
37
-7
-16% -$1.18K ﹤0.01% 328
2024
Q3
$8.53K Buy
44
+30
+214% +$6.28K ﹤0.01% 277
2024
Q2
$3.25K Buy
14
+1
+8% +$217 ﹤0.01% 379
2024
Q1
$2.8K Sell
13
-2
-13% -$468 ﹤0.01% 368
2023
Q4
$3.88K Buy
+15
New +$3.68K ﹤0.01% 277

Other funds holding BIIB

DiNuzzo Private Wealth's BIIB Position: Q3 2026 in Review

DiNuzzo Private Wealth reduced its Biogen (BIIB) stake by 5.6% in Q3 2026, selling an estimated $212 and leaving 17 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

DiNuzzo Private Wealth first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $8.53K in Q3 2024. 336 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • DiNuzzo Private Wealth held 17 shares of Biogen worth $3.84K as of Q3 2026.
  • DiNuzzo Private Wealth sold 1 Biogen share in Q3 2026, an estimated $212.
  • Biogen made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #468 holding.
  • DiNuzzo Private Wealth first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
  • DiNuzzo Private Wealth's Biogen position peaked at $8.53K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.